GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Savara Inc (STU:YB4P) » Definitions » Dividend-Payout-to-FFO

Savara (STU:YB4P) Dividend-Payout-to-FFO


View and export this data going back to 2009. Start your Free Trial

What is Savara Dividend-Payout-to-FFO?

Dividend-Payout-to-FFO only applies to REITs.


Savara (STU:YB4P) Business Description

Traded in Other Exchanges
Address
6836 Bee Cave Road, Building I, Suite 205, Austin, TX, USA, 78746
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's lead program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.